🇺🇸 Amoxicilline/clavulanic in United States
25 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 22 April 2025 – 22 April 2026
- Total reports: 25
Most-reported reactions
- Drug Interaction — 4 reports (16%)
- Abdominal Pain — 3 reports (12%)
- Anaemia — 3 reports (12%)
- Diarrhoea — 3 reports (12%)
- Back Pain — 2 reports (8%)
- Chest Pain — 2 reports (8%)
- Drug Ineffective — 2 reports (8%)
- Dysphagia — 2 reports (8%)
- Haemothorax — 2 reports (8%)
- Hypertension — 2 reports (8%)
Other Infectious Disease approved in United States
Frequently asked questions
Is Amoxicilline/clavulanic approved in United States?
Amoxicilline/clavulanic does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for Amoxicilline/clavulanic in United States?
Bayer is the originator. The local marketing authorisation holder may differ — check the official source linked above.